Pablo G. Legorreta, CEO, Chairman: Royalty Pharma RPRX Buy · Filed 23/05/17

Trade details

Type: Insider buy
Amount: $2,293,019.28
Shares · price: 69,612 sh · $32.94 a share
Held after: 230,000 sh
Stock: Royalty Pharma RPRX
Person: Pablo G. LegorretaCEO, Chairman
Trade date: 23/05/17
Filed: 23/05/17
Days to filing: 0 days

Holdings up 43.4%

Insiders buying this week: 1 insiders
Holding change: +43.4%

Royalty Pharma trades, last 26 weeks

What else happened in Royalty Pharma around then

Filed or reported within 30 days of the trade day · 23/04/17~23/06/16

Pablo G. Legorreta's recent trades

Pablo G. LegorretaDirector
BuyProkidney
Buy
Prokidney
PROK
$54.7M
22,617,909 sh
$54.7M
Filed 24/06/14
Traded 24/06/13
Pablo G. LegorretaCEO, Chairman
BuyRoyalty Pharma
Buy
Royalty Pharma
RPRX
$3.8M
130,000 sh
$3.8M
Filed 23/06/28
Traded 23/06/28
Pablo G. LegorretaCEO, Chairman
BuyRoyalty Pharma
Buy
Royalty Pharma
RPRX
$1.5M
45,000 sh
$1.5M
Filed 23/06/13
Traded 23/06/12
Pablo G. LegorretaCEO, Chairman
BuyRoyalty Pharma
Buy
Royalty Pharma
RPRX
$1.5M
45,000 sh
$1.5M
Filed 23/06/13
Traded 23/06/13
Pablo G. LegorretaCEO, Chairman
BuyRoyalty Pharma
Buy
Royalty Pharma
RPRX
$4.8M
150,000 sh
$4.8M
Filed 23/05/24
Traded 23/05/24